Logotype for Southern Archipelago Ltd

Southern Archipelago (A33) H2 2023 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Southern Archipelago Ltd

H2 2023 earnings summary

5 Nov, 2026

Executive summary

  • FY2023 revenue rose to S$5.20m from S$4.84m; net profit was S$44,433 versus a S$488,906 loss in FY2022. Sterilisation remained the main revenue and profit contributor.

  • A proposed hospitality and wellness asset acquisition was aborted on 29 December 2023; management is reassessing plans and continuing to explore other opportunities.

Financial highlights

  • Revenue was S$5.196m versus S$4.837m; profit before tax was S$587,258 versus S$64,787, and net profit was S$44,433 versus a S$488,906 loss.

  • Total expenses decreased to S$5.125m from S$7.220m; other gains fell to S$463,377 from S$2.352m, which included a prior-year S$1.809m gain on disposal of an asset held for sale.

  • Total comprehensive loss narrowed to S$366,869 from S$811,288, reflecting S$411,302 of other comprehensive loss in FY2023.

  • Operating cash flow was S$1.065m; investing cash outflow was S$1.254m and financing cash outflow was S$4.044m. Year-end cash was S$3.080m versus S$7.343m.

Outlook and guidance

  • Management expects the sterilisation business to perform well and generate positive operating cash flows over the next 12 months; PT Rel-ion is expected to remain a sizeable revenue contributor in FY2024.

  • Hospitality and wellness remains a targeted diversification area; management plans to seek new opportunities while reassessing its aborted acquisition plans.

  • Fundraising options under consideration include bank loans, shareholder loans or extensions, subsidiary loans and shareholder fundraising to support working capital as needed.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Southern Archipelago